Actemra 162 MG Prefiled Syringes 1'S
Form: Injection
Marketed by: CIPLA LTD (CANCER CARE)
MRP: ₹25461.00
Actemra 162mg by Cipla (tocilizumab 162 mg, 1 prefilled syringe) is an interleukin-6 (IL-6) receptor-blocking monoclonal antibody listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by rheumatologists for rheumatoid arthritis and giant cell arteritis. Schedule H: dispense only against a valid prescription. Counselling point: subcutaneous prefilled syringe; screen for TB before the first dose. Cold-chain item: store at 2-8°C, do not freeze.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.